Flucytosine (5-fluorocytosine) is an antimetabolite agent, classified as a systemic antifungal. It was first made in 1957 and FDA approved in 1971 for the treatment of severe candida and cryptococcus infections.

**FDA Approved Use**

Clinicians use flucytosine in combination with amphotericin B for invasive cryptococcal (meningitis) and candida infections.

**Other Use**

- Chromoblastomycosis

- Aspergillosis